Skip to main content

Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA’s Sentinel System

Basic Details
Date
Wednesday, October 31, 2018
Type
Publication
Medical Product
fentanyl transdermal system
Description

Fentanyl transdermal system (FTS) is intended only for patients with prior opioid tolerance. The purpose of this study is to identify the proportion of new FTS users who had evidence of prior opioid tolerance, by dosage strength, in FDA's Sentinel System. 

Materials

Pharmacoepidemiol Drug Saf. 2018 Oct 31. doi: 10.1002/pds.4677

Related Assessment(s)
2017 ICPE Presentation: Assessment of Prior Opioid Tolerance Among New Users of Fentanyl Transdermal System in FDA's Sentinel System
Counts and Proportions of New Users of Fentanyl Transdermal System with Evidence of Prior Opioid Tolerance
Author(s)

Noelle M. Cocoros, Marc R. Larochelle, Jennifer Popovic, Andrew B. Petrone, Cynthia Kornegay, Jing Ju, Judith A. Racoosin

Corresponding Author

Noelle M. Cocoros, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA 02215, USA. Email: noelle_cocoros@harvardpilgrim.org